Metals Acquisition Corp II
MTAL.U · NYSE
About MTAL.U
- Employees
- 0
- Headquarters
- George Town
- Listed
- Mar 12, 2026
- Sector
- N/A
- Industry
- N/A
MTAL.U key statistics
- Market cap
- 308.95M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 99
- Volume
- 501
- Open price
- $10.39
- High today
- $10.39
- Low today
- $10.39
- 52 Week high
- $11.40
- 52 Week low
- $10.03
Metals Acquisition Corp II (MTAL.U) at a glance
Metals Acquisition Corp II (MTAL.U) last traded at $10.39, with a market cap of 308.95M and a price-to-earnings ratio of 0.00.
Volume so far is 501 shares, above the average of 99 shares a day.
Over the past year Metals Acquisition Corp II has ranged from $10.03 to $11.40, and now sits 26% of the way up that range.
Most active stocks
Highest trading volume today
- BURUNuburu$0.287−22.79%
- INTCIntel$65.76−28.58%
- SLGBSmart Logistics Global$0.3051+48.97%
- AXXAExxe Group$0.0006+50.00%
- RDARRaadr$0.0002+0.00%
- SOXLDirexion Shares ETF Trust$77.05−24.75%
- HUBCHub Cyber Security$0.1134−16.00%
- RWAXTAP Real Estate Technologies$0.0002+0.00%
- NVDANVIDIA$204.64−4.20%
- NVDGraniteShares ETF Trust$4.43+8.19%
- SPCXSpace Exploration Technologies$134.69−6.39%
- GTVHGolden Triangle Ventures$0.0001+0.00%
Newly listed
Companies that went public in the past six weeks
- GBCGEORGIA BANKING$38.38+0.27%
- BHAIUBHAV Acquisition Corp II$9.98+0.00%
- SCQCUSPACCircle Acquisition$9.99+0.05%
- LYCALycia Therapeutics$26.40−4.80%
- DAVIDAVION HEALTHCARE$1.68−37.55%
- TCXBTCGX Acquisition Corp. II$10.14−0.66%
- CTYCITY THERAPEUTICS$20.71−6.46%
- IAMIambic Therapeutics$13.43−5.95%
- AMROAmaero$5.56−3.81%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.17−0.39%
- TRXBTRex Bio$13.74+1.63%
- RTSNRetension Pharmaceuticals$11.36−3.97%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.